• Mashup Score: 1

    Brugada syndrome (BrS) is an inherited cardiac channelopathy with variable expressivity that can lead to sudden cardiac arrest (SCA). Studies worldwide suggest that BrS and Brugada pattern (BrP) have low prevalences in general. However, studies also note that BrS is most prevalent among certain Asian populations. Among the different global regions, the highest prevalence is believed to be in…

    Tweet Tweets with this article
    • Brugada syndrome within Asian populations: State-of-the-art review | #THIPubs @MihailChelu | @CardiogenMDPI https://t.co/jzYMyqVjuT

  • Mashup Score: 0

    Complete atrioventricular block (AVB) is an abnormal heart rhythm resulting from a defect in the cardiac conduction system. Patients with complete AVB are at risk of symptoms ranging from syncope or hypotension to cardiovascular collapse or sudden cardiac death. A reliable animal model of complete AVB is essential for understanding the mechanisms underlying the fatal hemodynamic effects and…

    Tweet Tweets with this article
    • Use of ethanol injections to create a complete atrioventricular block in a rat model | #THIPubs @Abdou77762664 @MehdiRazavi13 @MathewsMakes @YutaoXiWFG | @Surgeries_MDPI https://t.co/XVpvv0rTki

  • Mashup Score: 0

    Abstract. Left ventricular assist devices (LVADs) are increasingly used to treat patients with end-stage heart failure. Implantable LVADs were initially developed in the 1960s and 1970s. Because of technological constraints, early LVADs had limited durability (eg, membrane or valve failure) and poor biocompatibility (eg, driveline infections and high rates of hemolysis caused by high shear…

    Tweet Tweets with this article
    • The evolution of durable, implantable axial-flow rotary blood pumps | #THIPubs #YaxinWangPhD #DrOHFrazier | @Texas_Heart #THIJournal https://t.co/HiRkgS5yxr

  • Mashup Score: 1

    Cardiac resynchronization therapy (CRT) is an established therapy for medically refractory heart failure (HF), with a reduction in hospitalization and mortality in addition to improved cardiac function and functional capacity shown in landmark clinical trials.1,2 Cardiac resynchronization therapy is also indicated for patients with systolic dysfunction requiring frequent ventricular pacing (>40%)…

    Tweet Tweets with this article
    • Conduction system pacing for cardiac resynchronization therapy: The 31-million-dollar question | #THIPubs @MihailChelu | @Texas_Heart #THIJournal https://t.co/d0tGfIvRWg